Articles

New combination drug has better efficacy in glucose control and weight loss than when taken separately.

Study tests new closed-loop control technology using new Control-IQ algorithm.

With pressure from patients, elected representatives and the medical community, we are finally seeing some positive results in lowering the cost of a life-sustaining drug.

Current and less-strict ADA recommendations found to achieve appropriate glycemic levels.

Dementia rates are higher among people who have type 1 diabetes and an A1C greater than 8%,

Free potential treatment lowers blood sugars, helps with weight loss, drops blood pressure and cholesterol, and may add at least 10 years of quality of life.

First oral GLP-1 agonist undergoing Phase 3 trials shows significant benefits managing type 2 diabetes.

Study looks at convenient once-weekly GLP-1 that can reduce chances of heart attacks and strokes.

Recommendations place special emphasis on youth newly diagnosed with diabetes.

Holistic approach revised, but there is still more to be done to individualize treatment.